Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Ladner

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Free Radical Research Communications|January 1, 1989
Decreased essential antioxidants and increased lipid hydroperoxides following high-dose radiochemotherapyM R Clemens, C Ladner, H Schmidt, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 15, 1992
Directed evolution of a protein: selection of potent neutrophil elastase inhibitors displayed on M13 fusion phageB L Roberts, W Markland, A C Ley, et al.
Bioconjugate Chemistry|January 24, 2012
Fibrin specific peptides derived by phage display: characterization of peptides and conjugates for imagingAndrew F Kolodziej, Shrikumar A Nair, Philip Graham, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1982
Gross quaternary changes in aspartate carbamoyltransferase are induced by the binding of N-(phosphonacetyl)-L-aspartate: A 3.5-A resolution studyJ E Ladner, J P Kitchell, R B Honzatko, et al.
Biotechnology and Bioengineering|May 28, 2011
Evaluation of protein engineering and process optimization approaches to enhance antibody drug manufacturabilityGreg P Conley, Malini Viswanathan, Ying Hou, et al.
Journal of Molecular Biology|September 15, 1982
Crystal and molecular structures of native and CTP-liganded aspartate carbamoyltransferase from Escherichia coliR B Honzatko, J L Crawford, H L Monaco, et al.
Neoplasia (New York, N.Y.)|November 22, 2007
PEGylated DX-1000: pharmacokinetics and antineoplastic activity of a specific plasmin inhibitorLaetitia Devy, Shafaat A Rabbani, Mark Stochl, et al.
Journal of Leukocyte Biology|August 5, 2006
Identification and characterization of a human monoclonal antagonistic antibody AL-57 that preferentially binds the high-affinity form of lymphocyte function-associated antigen-1Lili Huang, Motomu Shimaoka, Isaac J Rondon, et al.
Analytical Biochemistry|March 3, 2006
High-throughput affinity ranking of antibodies using surface plasmon resonance microarraysDina Wassaf, Guannan Kuang, Kris Kopacz, et al.
The Journal of Biological Chemistry|February 28, 2003
Novel peptide inhibitors of angiotensin-converting enzyme 2Lili Huang, Daniel J Sexton, Kirsten Skogerson, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Free Radical Research Communications|January 1, 1989
Decreased essential antioxidants and increased lipid hydroperoxides following high-dose radiochemotherapyM R Clemens, C Ladner, H Schmidt, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 15, 1992
Directed evolution of a protein: selection of potent neutrophil elastase inhibitors displayed on M13 fusion phageB L Roberts, W Markland, A C Ley, et al.
Bioconjugate Chemistry|January 24, 2012
Fibrin specific peptides derived by phage display: characterization of peptides and conjugates for imagingAndrew F Kolodziej, Shrikumar A Nair, Philip Graham, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1982
Gross quaternary changes in aspartate carbamoyltransferase are induced by the binding of N-(phosphonacetyl)-L-aspartate: A 3.5-A resolution studyJ E Ladner, J P Kitchell, R B Honzatko, et al.
Biotechnology and Bioengineering|May 28, 2011
Evaluation of protein engineering and process optimization approaches to enhance antibody drug manufacturabilityGreg P Conley, Malini Viswanathan, Ying Hou, et al.
Journal of Molecular Biology|September 15, 1982
Crystal and molecular structures of native and CTP-liganded aspartate carbamoyltransferase from Escherichia coliR B Honzatko, J L Crawford, H L Monaco, et al.
Neoplasia (New York, N.Y.)|November 22, 2007
PEGylated DX-1000: pharmacokinetics and antineoplastic activity of a specific plasmin inhibitorLaetitia Devy, Shafaat A Rabbani, Mark Stochl, et al.
Journal of Leukocyte Biology|August 5, 2006
Identification and characterization of a human monoclonal antagonistic antibody AL-57 that preferentially binds the high-affinity form of lymphocyte function-associated antigen-1Lili Huang, Motomu Shimaoka, Isaac J Rondon, et al.
Analytical Biochemistry|March 3, 2006
High-throughput affinity ranking of antibodies using surface plasmon resonance microarraysDina Wassaf, Guannan Kuang, Kris Kopacz, et al.
The Journal of Biological Chemistry|February 28, 2003
Novel peptide inhibitors of angiotensin-converting enzyme 2Lili Huang, Daniel J Sexton, Kirsten Skogerson, et al.
Pageof 5